SCHEDULE 13D/A: Coliseum Capital Boosts Stake in Purple Innovation, Provides $20 Million in New Debt Financing

Coliseum Capital Management and its affiliates have significantly increased their beneficial ownership in Purple Innovation, Inc. to 49.9% and provided an additional $20 million in senior secured term loan financing.

Summary

• Coliseum Capital Management, LLC and its affiliates, including Adam Gray and Christopher Shackelton, now beneficially own 61,131,909 shares of Purple Innovation, Inc.'s Class A Common Stock, representing 49.9% of the outstanding shares.
• This ownership includes 46,855,291 shares of Class A Stock and 14,276,618 shares that could be acquired upon exercise of Warrants, subject to a 49.9% Beneficial Ownership Cap.
• Purple Innovation, Inc. entered into a Credit Agreement Amendment on May 2, 2025, increasing its senior secured term loan facility by $20.0 million, raising the total loan amount from $80.0 million to $100.0 million.
• In connection with the Incremental Loan, the Company issued Incremental Warrants to purchase 6,557,377 shares of Class A Stock at an exercise price of $1.50 per share to the Second Amendment Term Loan Lenders.
• Coliseum Capital Partners, L.P. (CCP) received Incremental Warrants for 5,374,899 shares, and a Separate Account investment advisory client of CCM received Incremental Warrants for 1,182,478 shares.
• The Incremental Loan bears interest at the same rate as the Existing Loan, payable in cash or in kind at the Company's option.
• The Company paid various fees related to the amendment, including a 0.25% amendment fee (paid in kind), a 0.1% work fee (cash), a 0.15% waiver fee (cash), and a $150,000 commitment fee (cash).
• A Third Amended and Restated Registration Rights Agreement was also executed on May 2, 2025, providing for the registration of the Warrants and underlying Class A Stock for resale.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive. The company successfully secured additional financing from a key investor, indicating continued support and providing liquidity. However, this comes with increased debt and potential future equity dilution from the warrants, balancing the overall outlook.

Positives

• Purple Innovation secured an additional $20.0 million in financing, increasing its total senior secured term loan facility to $100.0 million, which provides additional liquidity.
• The continued investment and increased beneficial ownership by Coliseum Capital, a significant institutional investor, demonstrates ongoing support and confidence in the company.
• The new Registration Rights Agreement facilitates future liquidity for the holders of Warrants and Class A Stock, potentially making the investment more attractive.

Negatives

• The company incurred various fees associated with the Credit Agreement Amendment, including an amendment fee of 0.25%, a work fee of 0.1%, a waiver fee of 0.15% (all based on outstanding principal and accrued interest), and a $150,000 commitment fee.
• The issuance of Incremental Warrants to purchase 6,557,377 shares of Class A Stock at $1.50 per share represents potential future dilution for existing shareholders upon exercise.
• The increase in the senior secured term loan facility adds to the company's debt burden.

Risks

• The Beneficial Ownership Cap of 49.9% limits the immediate exercise of all Warrants held by Coliseum Capital and its affiliates, meaning a portion of their potential ownership is not yet realized.
• Future exercise of the Warrants could lead to dilution of existing shareholders' equity.
• The company's increased debt load from the $20.0 million Incremental Loan could impact its financial flexibility and debt servicing capacity.

Future Outlook

The Credit Agreement Amendment allows Purple Innovation to request one or more additional term loans in an initial aggregate principal amount not to exceed $20.0 million, subject to lender approval. The Issuer is also required to file a registration statement with the SEC by May 30, 2025 (or July 16, 2025, if Form S-3 is unavailable) to register the resale of the Warrants and underlying Class A Stock.

Industry Context

This filing indicates a significant financing event for Purple Innovation, Inc., securing additional capital from a major existing investor. While not directly reflective of broader industry trends, it highlights the company's ability to access capital and the continued strategic involvement of key shareholders like Coliseum Capital in its financial structure and future.

Corporate Governance

Related Party Transactions

• Coliseum Capital Partners, L.P. (CCP) and a Separate Account investment advisory client of Coliseum Capital Management, LLC provided a significant portion of the $20.0 million Incremental Loan to Purple LLC, a subsidiary of the Issuer.
• In return for their loan contributions, CCP and the Separate Account received Incremental Warrants to acquire 5,374,899 and 1,182,478 shares of Class A Stock, respectively.
• Coliseum Capital Management, LLC and its affiliates are significant beneficial owners of Purple Innovation, Inc., and Adam Gray, a manager of Coliseum Capital Management, LLC, is a director of the Issuer. This transaction involves entities controlled by or affiliated with a major shareholder and board member.

Stakeholder Impact

• Shareholders: Potential for future dilution due to the exercise of newly issued warrants, but also benefit from the company securing additional capital for operations.
• Creditors: The company's debt burden has increased by $20.0 million, which could affect its credit profile.
• Coliseum Capital and its affiliates: Their beneficial ownership has increased, solidifying their influence and potential returns, and they have secured warrants providing future upside potential.

Next Steps

• The Issuer is required to prepare and file a registration statement with the SEC by May 30, 2025 (or July 16, 2025, if Form S-3 is not then available) to register the resale of the Registrable Securities (Warrants and Class A Stock).

Key Dates

Recommendation

Keywords

Purple Innovation, Coliseum Capital, SEC Filing, Schedule 13D, Class A Common Stock, Warrants, Debt Financing, Credit Agreement, Beneficial Ownership, Registration Rights, Equity Dilution, Corporate Governance